GlassScriptPhysician profile
Andrew M Jen
NPI 1548647829
$5,690.39
in general payments reported to CMS, 2019-2025
18 companies · $1,331 in 2025
The $1,331 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $989 · 2022: $1,404 · 2023: $1,364 · 2024: $602 · 2025: $1,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,160 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,159.60 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,843.95 | 2021-2025 | Mako, T2 Alpha, Insignia |
| Depuy Synthes Sales INC. | $677.77 | 2021-2025 | Va-Lcp, Na, Fibulink |
| Zimmer Biomet Holdings, INC. | $356.76 | 2022-2025 | Persona, Rosa |
| Medical Device Business Services, INC. | $341.52 | 2022-2025 | Vistaseal |
| Davol INC. | $322.33 | 2024-2025 | Arista, Arista Ah Flexitip |
| Smith+Nephew, INC. | $311.49 | 2023-2024 | Evos, Trigen Intertan |
| Pylant Medical | $166.63 | 2024-2025 | |
| Acumed LLC | $149.42 | 2022 | |
| Medacta USA, INC. | $149.07 | 2023 | Amistem |
| Biocomposites INC | $136.74 | 2025 | Stimulan |
| Vertex Pharmaceuticals Incorporated | $45.42 | 2025 | |
| Flower Orthopedics Coporation | $39.41 | 2024 | |
| Orthofix Medical, INC. | $38.61 | 2022-2023 | Physio-Stim |
| Globus Medical, INC. | $29.76 | 2025 | Autobahn, Anthem |
| Abbvie INC. | $25.60 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $20.20 | 2023 | Seglentis |
| Heraeus Medical, LLC. | $18.44 | 2022 | |
| Vericel Corporation | $17.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Jen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.